We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Protein Patterning: Novel Tool for Studying Sepsis

By LabMedica International staff writers
Posted on 18 Jan 2016
In a new approach using quantitative targeted proteomics, researchers have for the first time developed a way to use mass-spectrometry to measure hundreds of organ proteins in a single blood sample. More...
The resulting protein patterns can help determine sepsis severity, which organs have been damaged, and may lead to faster diagnostics.

“We use the blood as a mirror reflecting what happens in the body,” said Johan Malmström biomedical scientist at Lund University (Lund, Sweden), whose brothers, medical intern Erik Malmström (Lund U.) and bioinformatician Lars Malmström University of Zurich (Zurich, Switzerland) are fellow researchers on the study. The team has succeeded to map the majority of all detected proteins from vital organs (e.g., heart, lung, liver, spleen, blood vessels) and have listed which proteins were specific to each organ.

“If you see in a blood sample that the amount of proteins from a specific organ significantly increases, it indicates damage to this organ. The method provides an understanding of the molecular events that take place during the course of a disease, and the possibility, using the same analysis, to study how different organs are affected”, explained Dr. E. Malmström.

Sepsis is a very complicated and precarious condition in which the immune system starts to react erroneously in different ways to the bacterial infection. It is often difficult to diagnose because symptoms (including high breathing rate, fever, rapid pulse, pain, confusion) occur in milder conditions as well. Disease progression can be very fast and become fatal within a few hours. Therefore, there is a great need for faster diagnosis and better understanding of the course of the disease.

Another researcher, Dr. Adam Linder (Lund U.), has begun to develop a diagnostic method based on HBP, a protein emitted from white blood cells and reflects the risk of hypotension. The Malmström group’s study of hundreds of different proteins could eventually be used to select other important proteins that can serve as biomarkers for different aspects of sepsis.

The new method is already an important research tool: “There is so much we don’t know about sepsis. Why do not all patients react the same way—why do some organs suffer the most damage in some patients and not in others? Do different bacteria cause the disease to progress? Can you divide patients into different subgroups, or bacteria, or does each new combination of patients and bacteria lead to a specific form of sepsis?” asked Dr. E. Malmström. The researchers have conducted their studies on animals and are now moving on to human tissue. Through a collaboration with surgeons at Skane University Hospital they have obtained samples of healthy tissue. Protein patterns of these samples can then be compared with the corresponding organ tissues in sepsis patients.

“Protein mapping like this has never been done before. The method can also be applied to other diseases for studying how pathological changes in various organs are reflected in a blood sample,” said Dr. Johan Malmström.

The study, by Malmström E, Kilsgard O, Hauri S, Smeds E, Herwald H, Malmström L, & Malmström J, was published January 6, 2016, in the journal Nature Communications.

Related Links:

Lund University
University of Zurich 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.